Cite
Lopinavir/ritonavir resistance in patients infected with HIV-1: two divergent resistance pathways?
MLA
Karen Champenois, et al. “Lopinavir/Ritonavir Resistance in Patients Infected with HIV-1: Two Divergent Resistance Pathways?” Journal of Medical Virology, vol. 83, no. 10, May 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa6b602511c08b5b50d7565f9b9716ae&authtype=sso&custid=ns315887.
APA
Karen Champenois, Agathe Baras, Faiza Ajana, Laurence Bocket, Philippe Choisy, Yazdan Yazdanpanah, & Hughes Melliez. (2011). Lopinavir/ritonavir resistance in patients infected with HIV-1: two divergent resistance pathways? Journal of Medical Virology, 83(10).
Chicago
Karen Champenois, Agathe Baras, Faiza Ajana, Laurence Bocket, Philippe Choisy, Yazdan Yazdanpanah, and Hughes Melliez. 2011. “Lopinavir/Ritonavir Resistance in Patients Infected with HIV-1: Two Divergent Resistance Pathways?” Journal of Medical Virology 83 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa6b602511c08b5b50d7565f9b9716ae&authtype=sso&custid=ns315887.